E-course: The role of focal therapy in prostate cancer for kidney transplant patients

This e-course will present evidence which will demonstrate the role of focal therapy as an alternative in the management of a heterogeneous disease such as prostate cancer (PCa) in the high-risk population of kidney transplant patients and/or candidates.

Published Tue, 25 Jul 2023
E CourseTransplantationProstate CancerOncologyFocal TherapyProstate CancerKidney TransplantationEAU Section Of Transplantation UrologyEAU Guidelines Office
Organiser European School of Urology (ESU)
CME 1.00
Duration Approx. 60 minutes

Organ-sparing approaches in the management of localised PCa were developed in part to overcome the morbidity associated with standard whole-gland treatment options. This can be crucial in kidney transplant patients and/or candidates.

Focal therapy was introduced and defined over two decades ago and since then, substantial developments have taken place. The evolution of patient selection; the approach to ablation; surveillance after focal therapy; and improved understanding of the biology of low-grade, low-risk PCa have mirrored the technological advancements in the field.

Prof. Dr. E. Lledó García (ES)
Dr. E. Barret (FR)
Dr. C. Martinez Ballesteros (ES)
Prof. Dr. J.I. Martínez Salamanca (ES)

Contact our organiser

European School of Urology (ESU)

Email:  educationonline@uroweb.org